Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?

Abstract

In the present Frontier article, we highlight recent new results on the use of platinoid complexes as therapeutic agents against Alzheimer's disease and infer the relevance of targeting monomeric soluble disordered amyloid peptides to preclude the deleterious aggregation process associated with the etiology of the disease.